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Background
The ability to interpret environmental signals is a funda-
mental feature to ensure the integrity and survival of liv-
ing organisms. The nociceptors are a group of sensory
terminals that can detect a variety of noxious stimuli
such as thermal or chemical stimuli, and are related with
the generation of the pain signal and inflammation.
These sensors have the ability to respond to capsaicin,
the pungent agent of chilli peppers, which allowed the
identification of TRPV1, a polymodal non-selective
cation channel, tightly related with the generation of
acute and neurogenic pain. TRPV1 is a member of the
Transient Potential Receptor (TRP) family. It can be acti-
vated by noxious temperature (>42°C), low pH and
ligands like capsaicin and resiniferatoxin. Even when the
physiology of the channel has been characterized in some
detail, the structural events that the channel undergoes
during gating are still unknown. Recently the TRPV1
structure was resolved by electron cryomicroscopy in a
fully closed conformation and in complex with activators
such as capsaicin, allowing us to get insight of the dis-
tinct conformations of TRPV1. Consequently, the under-
standing of the structural background of the channel
gating in a ligand-dependent manner provides exciting
opportunities for pharmacological intervention.
Results
The aim of this research is to identify novel activators of
TRPV1 in a rational framework, taking the characteriza-
tion of capsaicin as a model for structure-ligand interac-
tion and to unravel the structure-function relationship
involved in channel gating via molecular dynamics (MD)
simulations. We have analyzed the vanilloid binding site
within the third and fourth transmembrane segments,
revealing a hydrophobic pocket with a marked presence of
polar residues on the intracellular edge of the membrane.
Furthermore, our MD assays has been shown that the cap-
saicin-dependent activation of the channel involves a shift
in the curvature of the ‘S6-TRP domain’ segment disrupt-
ing the pore domain, presumably providing the first step
for the ligand-dependent channel gating and thus reveal-
ing the great relevance of the vanilloid binding site to the
channel opening. Molecular docking assays indicates the
influence of the polar residues in the orientation of capsai-
cin in the binding pocket showing the vanilloid ring facing
the polar residues and the aliphatic ramification pointing
to the center of the membrane. These findings will allow
us to perform a rational search strategy of novel TRPV1
activators, testing a database of 112.935 molecules with a
massive molecular docking strategy. As a first approach
we have selected a group of 10 molecules using the bind-
ing affinity and the hydrophobicity relative to capsaicin as
selection criteria. Our goal is to contribute to the develop-
ment of novel analgesic drugs and to increase the knowl-
edge of the gating of this class of ion channels.
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